ASTION PHARMA A/S: Financial statements 2017
CVR: 34224781
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -47,792 and a net result of DKK -1,543,930 compared with DKK 116,538 the year before. Equity in the 2017 report amounted to DKK 7,681,210. The solvency ratio was 71.1%.
- Gross Profit
- DKK -47,792
- Profit/Loss
- DKK -1,543,930
- Equity
- DKK 7,681,210
- Total Assets
- DKK 10,800,213
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | -48 t. | -1.5 mio. | 7.7 mio. | 0 |
| 2016 | - | -187 t. | 117 t. | 15.7 mio. | 0 |
| 2015 | - | -783 t. | -5.8 mio. | 15.6 mio. | - |
| 2014 | - | -1.2 mio. | -3.4 mio. | 21.3 mio. | - |
| 2013 | - | -804 t. | -1.5 mio. | 24.8 mio. | - |
Official annual report
Keep an eye on ASTION PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ASTION PHARMA A/S has published its annual report for 2016. Gross profit came to DKK -187,484, and the net result was DKK 116,538.
About ASTION PHARMA A/S
ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.